These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 30636332)

  • 1. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
    Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
    Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
    Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
    Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
    Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X; Pang Y; Qiao J
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
    Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
    Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-group-specific reference intervals for anti-Müllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population.
    Song J; Park Y; Cho HW; Lee SG; Kim S; Lim JB
    J Clin Lab Anal; 2021 Jul; 35(7):e23861. PubMed ID: 34097316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.